Free Trial

DexCom (DXCM) SEC Filings & 10K Form

DexCom logo
$88.78 -0.56 (-0.63%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$89.64 +0.86 (+0.97%)
As of 02/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent DexCom SEC Filings

DateFilerForm TypeView
02/18/2025
5:06 AM
DexCom (Filer)
Form S-3ASR
01/30/2025
5:43 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:44 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:44 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:44 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:44 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:31 AM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:05 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
3:15 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
10:56 AM
DexCom (Subject)
Heller Bridgette P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:15 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2024
4:13 PM
DexCom (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:04 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
3:17 PM
DexCom (Issuer)
Heller Bridgette P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:53 AM
DexCom (Subject)
Heller Bridgette P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
6:05 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:05 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:05 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:22 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
6:23 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:04 PM
Brown Michael Jon (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
4:18 PM
DexCom (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
3:05 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
4:34 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:50 PM
DexCom (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
6:16 PM
DexCom (Issuer)
Heller Bridgette P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
9:30 AM
DexCom (Subject)
Heller Bridgette P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
5:38 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:39 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:39 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
4:27 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:59 PM
DexCom (Filer)
Form SD
Specialized Disclosure Report  
05/24/2024
4:38 PM
ALTMAN STEVEN R (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:39 PM
AUGUSTINOS NICHOLAS (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:39 PM
Collins Richard Alexander (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:40 PM
Dahut Karen M (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:40 PM
DexCom (Issuer)
Driscoll Rimma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:40 PM
DexCom (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:40 PM
DexCom (Issuer)
Heller Bridgette P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:41 PM
DexCom (Issuer)
Malady Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:41 PM
DexCom (Issuer)
TOPOL ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Why Buffett and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

05/15/2024
3:55 PM
DexCom (Subject)
Dolan Matthew Vincent (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2024
4:17 PM
DexCom (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2024
3:32 PM
DexCom (Filer)
Form DEF 14A
04/22/2024
3:39 PM
DexCom (Filer)
Form ARS
04/16/2024
3:16 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:04 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
5:22 PM
DexCom (Subject)
Naganathan Girish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
6:30 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Brown Michael Jon (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
3:46 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:08 PM
Abbey Donald (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:09 PM
DexCom (Subject)
Flynn Paul R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:10 PM
DexCom (Subject)
Stern Sadie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2024
3:55 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:37 PM
DexCom (Subject)
Dolan Matthew Vincent (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:39 PM
DexCom (Subject)
Flynn Paul R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
4:39 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:39 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:39 PM
DexCom (Issuer)
Lawver Teri L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:40 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:40 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:40 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:40 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:30 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:30 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:31 PM
DexCom (Issuer)
Lawver Teri L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:31 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:31 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:32 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:32 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
4:31 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
4:48 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DXCM) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners